The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites
Open accessPublished version of a preprint
Abstract
The outbreak of coronavirus disease (COVID-19) in China caused by SARS-CoV-2 virus continually lead to worldwide human infections and deaths. It is currently no specific viral protein targeted therapeutics yet. Viral nucleocapsid protein is a potential antiviral drug target, serving multiple critical functions during the viral life cycle. However, the structural information of SARS-CoV-2 nucleocapsid protein is yet to be clear. Herein, we have determined the 2.7 Å crystal structure of the N-terminal RNA binding domain of SARS-CoV-2 nucleocapsid protein. Although overall structure is similar with other reported coronavirus nucleocapsid protein N-terminal domain, the surface electrostatic potential characteristics between them are distinct. Further comparison with mild virus type HCoV-OC43 equivalent domain demonstrates a unique potential RNA binding pocket alongside the β-sheet core. Complemented by in vitro binding studies, our data provide several atomic resolution features of SARS-CoV-2 nucleocapsid protein N-terminal domain, guiding the design of novel antiviral agents specific targeting to SARS-CoV-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Self-citationFast, scalable generation of high‐quality protein multiple sequence alignments using Clustal Omega
Sievers, F., Wilm, A., Dineen, D., Gibson, T. J., Karplus, K., Li, W., Lopez, R., McWilliam, H., Remmert, M., Söding, J., et al. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.75 · Cited by 15,355
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Liebschner, D., Afonine, P. V., Baker, M. L., Bunkóczi, G., Chen, V. B., Croll, T. I., Hintze, B., Hung, L.-W., Jain, S., McCoy, A. J., et al. (2019) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798319011471 · Cited by 7,953
Deciphering key features in protein structures with the new ENDscript server
Robert, X., & Gouet, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku316 · Cited by 7,053
Origin and evolution of pathogenic coronaviruses
Cui, J., Li, F., & Shi, Z.-L. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,515
Guo (2020) · doi:10.1186/s40779-020-00240-0 · Cited by 4,735
Scaling and assessment of data quality
Evans, P. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905036693 · Cited by 4,374
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
An introduction to data reduction: space-group determination, scaling and intensity statistics
Evans, P. R. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s090744491003982x · Cited by 1,485
Ahmed, S. F., Quadeer, A. A., & McKay, M. R. (2020) · Viruses · doi:10.3390/v12030254 · Cited by 1,116
The Coronavirus Nucleocapsid Is a Multifunctional Protein
McBride, R., Van Zyl, M., & Fielding, B. (2014) · Viruses · doi:10.3390/v6082991 · Cited by 942
Nidovirales: Evolving the largest RNA virus genome
Gorbalenya, A. E., Enjuanes, L., Ziebuhr, J., & Snijder, E. J. (2006) · Virus Research · doi:10.1016/j.virusres.2006.01.017 · Cited by 922
Improved R-factors for diffraction data analysis in macromolecular crystallography
Diederichs, K., & Karplus, P. A. (1997) · Nature Structural Biology · doi:10.1038/nsb0497-269 · Cited by 838
Coronavirus Genome Structure and Replication
Brian, D. A., & Baric, R. S. (2005) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-26765-4_1 · Cited by 752
Global indicators of X-ray data quality
Weiss, M. S. (2001) · Journal of Applied Crystallography · doi:10.1107/s0021889800018227 · Cited by 684
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
Wan, Y., Shang, J., Sun, S., Tai, W., Chen, J., Geng, Q., He, L., Chen, Y., Wu, J., Shi, Z., et al. (2020) · Journal of Virology · doi:10.1128/jvi.02015-19 · Cited by 662
Volkamer, A., Kuhn, D., Rippmann, F., & Rarey, M. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts310 · Cited by 613
Virus Variation Resource – improved response to emergent viral outbreaks
Hatcher, E. L., Zhdanov, S. A., Bao, Y., Blinkova, O., Nawrocki, E. P., Ostapchuck, Y., Schäffer, A. A., & Brister, J. R. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1065 · Cited by 449
Cong, Y., Ulasli, M., Schepers, H., Mauthe, M., V’kovski, P., Kriegenburg, F., Thiel, V., de Haan, C. A. M., & Reggiori, F. (2020) · Journal of Virology · doi:10.1128/jvi.01925-19 · Cited by 384
Modular organization of SARS coronavirus nucleocapsid protein
Chang, C.-K., Sue, S.-C., Yu, T.-H., Hsieh, C.-M., Tsai, C.-K., Chiang, Y.-C., Lee, S.-J., Hsiao, H.-H., Wu, W.-J., Chang, W.-L., et al. (2006) · Journal of Biomedical Science · doi:10.1007/s11373-005-9035-9 · Cited by 319
Ahmed, S. F., Quadeer, A. A., & McKay, M. R. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.03.933226 · Cited by 256
Surjit, M., Liu, B., Chow, V. T. K., & Lal, S. K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509233200 · Cited by 212
Hsieh, P.-K., Chang, S. C., Huang, C.-C., Lee, T.-T., Hsiao, C.-W., Kou, Y.-H., Chen, I.-Y., Chang, C.-K., Huang, T.-H., & Chang, M.-F. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.13848-13855.2005 · Cited by 200
Pathogenesis of severe acute respiratory syndrome
Lau, Y. L., & Peiris, J. M. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.05.009 · Cited by 168
Fan, H., Ooi, A., Tan, Y. W., Wang, S., Fang, S., Liu, D. X., & Lescar, J. (2005) · Structure · doi:10.1016/j.str.2005.08.021 · Cited by 160
Grossoehme, N. E., Li, L., Keane, S. C., Liu, P., Dann, C. E., Leibowitz, J. L., & Giedroc, D. P. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.09.040 · Cited by 148
Jayaram, H., Fan, H., Bowman, B. R., Ooi, A., Jayaram, J., Collisson, E. W., Lescar, J., & Prasad, B. V. V. (2006) · Journal of Virology · doi:10.1128/jvi.00157-06 · Cited by 147
Saikatendu, K. S., Joseph, J. S., Subramanian, V., Neuman, B. W., Buchmeier, M. J., Stevens, R. C., & Kühn, P. (2007) · Journal of Virology · doi:10.1128/jvi.02236-06 · Cited by 138
Lin, S.-Y., Liu, C., Chang, Y., Zhao, J., Perlman, S. M., & Hou, M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500089r · Cited by 137
Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates
Liu, S., Leng, C. H., Lien, S., Chi, H.-Y., HUANG, C., LIN, C., Wu, L., Chen, C., HSIEH, S., & Chong, P. C.-S. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.01.058 · Cited by 120
Characterization of viral proteins encoded by the SARS-coronavirus genome
Tan, Y., Lim, S. G., & Hong, W. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2004.10.001 · Cited by 118
Chang, C., Chen, C.-M. M., Chiang, M.-H., Hsu, Y.-L., & Huang, T.-H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065045 · Cited by 110
Lin, S., Lin, S., Hsu, J.-N., Chang, C., Chien, C., Wang, Y., Wu, H., Jeng, U., Kehn‐Hall, K., & Hou, M. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01913 · Cited by 109
Identification of an epitope of SARS-coronavirus nucleocapsid protein
Lin, Y. C., Shen, X., Rui Fu, Y. A. N. G., Li, Y. X., Ji, Y., He, Y., Shi, M., Lü, W., Shi, T. L., Wang, J., et al. (2003) · Cell Research · doi:10.1038/sj.cr.7290158 · Cited by 107
Ramajayam, R., Tan, K.-P., & Liang, P. (2011) · Biochemical Society Transactions · doi:10.1042/bst0391371 · Cited by 100
Tan, Y. W., Fang, S., Fan, H., Lescar, J., & Liu, D. X. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl650 · Cited by 95
Oligomerization of the carboxyl terminal domain of the human coronavirus 229E nucleocapsid protein
Lo, Y.-S., Lin, S.-Y., Wang, S.-M., Wang, C.-T., Chiu, Y.-L., Huang, T.-H., & Hou, M. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.11.016 · Cited by 94
Du, L., Zhao, G., Lin, Y., Chan, C. C. S., He, Y., Jiang, S., Wu, C. Y., Jin, D., Yuen, K., Zhou, Y., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.01.025 · Cited by 86
Tang, T., Wu, M. P. ‐., Chen, S., Hou, M., Hong, M., Pan, F., Yu, H., Chen, J., Yao, C., & Wang, A. H. ‐. (2005) · PROTEOMICS · doi:10.1002/pmic.200401204 · Cited by 60
Self-citationChen, I.-J., Yuann, J. P., Chang, Y., Lin, S.-Y., Zhao, J., Perlman, S. M., Shen, Y.-Y., Huang, T.-H., & Hou, M. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.03.003 · Cited by 49
Research works printed but not linked: 7
- Guo, 2020, The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak—an update on the status, Mil Med Res, 7, 11
- Nelson, 2000, High affinity interaction between nucleocapsid protein and leader/intergenic sequence of mouse hepatitis virus RNA, J Gen Virol, 81, 181
- Stohlman, 1988, Specific interaction between coronavirus leader RNA and nucleocapsid protein, J Virol, 62, 4280, 10.1128/jvi.62.11.4288-4295.1988 · doi:10.1128/jvi.62.11.4288-4295.1988
- Masters, 1990, Background paper: functions of the coronavirus nucleocapsid protein, Adv Exp Med Biol, 276, 235, 10.1007/978-1-4684-5823-7_32 · doi:10.1007/978-1-4684-5823-7_32
- Shang, 2005, Characterization and application of monoclonal antibodies against N protein of SARS-coronavirus, Biochem Biophys Res Commun, 336, 110, 10.1016/j.bbrc.2005.08.032 · doi:10.1016/j.bbrc.2005.08.032
- Wootton, 2002, Phosphorylation of the porcine reproductive and respiratory syndrome virus nucleocapsid protein, J Virol, 76, 10569, 10.1128/JVI.76.20.10569-10576.2002 · doi:10.1128/jvi.76.20.10569-10576.2002
- Keane, 2012, Functional transcriptional regulatory sequence (TRS) RNA binding and helix destabilizing determinants of murine hepatitis virus (MHV) nucleocapsid (N) protein, J Biol Chem, 287, 7063, 10.1074/jbc.M111.287763 · doi:10.1074/jbc.m111.287763
Cited by
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Bouhaddou, M., Memon, D., Meyer, B., White, K. M., Rezelj, V. V., Correa Marrero, M., Polacco, B. J., Melnyk, J. E., Ulferts, S., Kaake, R. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.034 · Cited by 1,020
The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections
Machhi, J., Herskovitz, J., Senan, A. M., Dutta, D., Nath, B., Oleynikov, M. D., Blomberg, W. R., Meigs, D. D., Hasan, M., Patel, M., et al. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09944-5 · Cited by 617
The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA
Cubuk, J., Alston, J. J., Incicco, J. J., Singh, S., Stuchell-Brereton, M. D., Ward, M. D., Zimmerman, M. I., Vithani, N., Griffith, D., Wagoner, J. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21953-3 · Cited by 576
Davidson, A. D., Williamson, M. K., Lewis, S., Shoemark, D., Carroll, M. W., Heesom, K. J., Zambon, M., Ellis, J., Lewis, P. A., Hiscox, J. A., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-00763-0 · Cited by 457
COVID-19: Drug Targets and Potential Treatments
Gil, C., Ginex, T., Maestro, I., Nozal, V., Barrado-Gil, L., Cuesta-Geijo, M. Á., Urquiza, J., Ramírez, D., Alonso, C., Campillo, N. E., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00606 · Cited by 445
Metadata
- Authors
- Kang, S., Yang, M., Hong, Z., Zhang, L., Huang, Z., Chen, X., He, S., Zhou, Z., Zhou, Z., Chen, Q., Yan, Y., Zhang, C., Shan, H., & Chen, S.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 10
- Issue
- 7
- Pages
- 1228-1238
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W3016553966
- Cited by
- 632
- References
- 43
- FWCI
- 16.36
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- National Natural Science Foundation of China (31770801)
- Chinese Academy of Sciences
- National Key Research and Development Program of China (81870019, SQ2018YFC090075)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.